Robotic adrenalectomy in patients with pheochromocytoma: a systematic review.
-
Authors
-
-
Bihain, Florence1
-
Klein, Marc2
-
Nomine-Criqui, Claire1
-
Brunaud, Laurent1
-
1
Département de Chirurgie Viscérale, Métabolique et Cancérologique (CVMC), Unité multidisciplinaire de chirurgie métabolique, endocrinienne et thyroïdienne (UMET), CHRU Brabois, Université de Lorraine, Nancy, France.
,
(France)
-
2
Service d'Endocrinologie, Diabétologie et Nutrition, Unité multidisciplinaire de chirurgie métabolique, endocrinienne et thyroïdienne (UMET), CHRU Brabois, Université de Lorraine, Nancy, France.
,
(France)
- Type
- Published Article
- Journal
-
Gland surgery
- Publication Date
-
Jun 01, 2020
- Volume
-
9
- Issue
-
3
- Pages
-
844–848
- Identifiers
-
DOI: 10.21037/gs-2019-ra-05
-
PMID: 32775278
- Source
-
Medline
- Keywords
-
- Language
-
English
- License
-
Unknown
Abstract
Pheochromocytomas (PHEOs) are neural crest cell tumors producing catecholamines. PHEOS need to be early diagnosed and adequately managed. Adrenalectomy is the gold standard treatment of these type of tumors. There has been major improvement of surgical technologies with the development of laparoscopic and robotic systems these past several years. We conducted a review of the literature to evaluate the robotic approach for adrenalectomy for patients with PHEO. 2020 Gland Surgery. All rights reserved.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/04/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/32775278
